It is commonly believed that the combination of antidepressant medications (ADM) and psychotherapy is more effective in the treatment of depression than is either treatment alone. There is evidence that adding cognitive therapy (CT) enhances the initial effects of ADM, but most of the relevant studies have suffered from low power. Moreover, findings from numerous studies suggest that CT has an enduring effect, but most of the evidence has been relevant to the prevention of relapse - the return of symptoms associated with the treated episode. There is little evidence on what is arguably the more critical prevention question: whether prior exposure to CT prevents recurrence - the onset of new episodes. What is needed is a study that is sensitive enough to detect the benefits that might accompany the addition of CT to ADM, and that can begin to address the attendant cost-effectiveness questions. The proposed design combines the goals and methods of efficacy and effectiveness research to these ends. We plan to randomly assign 450 depressed outpatients (150 at each of three sites) to ADM alone or to ADM plus CT. All patients will be treated to remission with a clinically representative ADM regimen, and half will, in addition, receive CT. Remitted patients will then be continued on medications for up to 12 months until they meet criteria for recovery, during which time CT will be continued as clinically indicated for patients in combined treatment. Once recovered, patients will be randomly assigned to either maintenance medications or medication withdrawal. Shortly thereafter, patients who have been receiving CT will be withdrawn from it as well. Patients will then be followed for a three-year period for the purpose of detecting recurrences. The main hypotheses are: (1) initial response will be better in ADM plus CT, relative to ADM alone; and (2) prior exposure to CT will protect against subsequent recurrence following medication withdrawal, to the same extent as maintenance ADM. Analyses will be employed to estimate the relative cost-effectiveness of adding CT to ADM for acute response and recurrence prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH060998-01A2
Application #
6332095
Study Section
Special Emphasis Panel (ZMH1-ITV-D (01))
Program Officer
Niederehe, George T
Project Start
2002-07-16
Project End
2007-03-31
Budget Start
2002-07-16
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$792,026
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Furukawa, Toshi A; Weitz, Erica S; Tanaka, Shiro et al. (2017) Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry 210:190-196
Cooper, Andrew A; Strunk, Daniel R; Ryan, Elizabeth T et al. (2016) The therapeutic alliance and therapist adherence as predictors of dropout from cognitive therapy for depression when combined with antidepressant medication. J Behav Ther Exp Psychiatry 50:113-9
Vittengl, Jeffrey R; Jarrett, Robin B; Weitz, Erica et al. (2016) Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. Am J Psychiatry 173:481-90
Lorenzo-Luaces, Lorenzo; German, Ramaris E; DeRubeis, Robert J (2015) It's complicated: The relation between cognitive change procedures, cognitive change, and symptom change in cognitive therapy for depression. Clin Psychol Rev 41:3-15
Hollon, Steven D; DeRubeis, Robert J; Fawcett, Jan et al. (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71:1157-64
Derubeis, Robert J; Gelfand, Lois A; German, Ramaris E et al. (2014) Understanding processes of change: how some patients reveal more than others-and some groups of therapists less-about what matters in psychotherapy. Psychother Res 24:419-28
DeRubeis, Robert J; Cohen, Zachary D; Forand, Nicholas R et al. (2014) The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One 9:e83875
Cuijpers, Pim; Weitz, Erica; Twisk, Jos et al. (2014) Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an ""individual patient data"" meta-analysis. Depress Anxiety 31:941-51
Lorenzo-Luaces, Lorenzo; DeRubeis, Robert J; Webb, Christian A (2014) Client characteristics as moderators of the relation between the therapeutic alliance and outcome in cognitive therapy for depression. J Consult Clin Psychol 82:368-73
Amsterdam, Jay D; Luo, Lola; Shults, Justine (2013) Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder. Br J Psychiatry 202:301-6

Showing the most recent 10 out of 22 publications